跳至主要内容
临床试验/NCT00479726
NCT00479726已完成4 期

Lilly's Emotional and Physical Symptoms of Depression Study

Eli Lilly and Company1 个研究点 分布在 1 个国家目标入组 8,000 人开始时间: 2004年8月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
8,000
试验地点
1
主要终点
Clinical Global Impression of Severity

研究概览

简要总结

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

详细描述

To assess physical and emotional symptoms of depressed patients

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Are investigator site personnel directly affiliated with the study or immediate family
  • Are employed by Eli Lilly and Company
  • Have received treatment within the last 30 days or are currently enrolled in a study with a drug that has not received regulatory approval for any indication at time of study entry
  • Current substance dependence, excluding nicotine and caffeine
  • Treatment with a monoamine oxidase inhibitor within 14 days prior to visit 1 or potential need to use an MAOI within 5 days after discontinuation of study drug
  • Acute liver injury or severe (Child-Pugh Class C) cirrhosis

结局指标

主要结局

Clinical Global Impression of Severity

Somatic Symptom Inventory

Depressive Symptomatology-Self Report

次要结局

  • Patient Global Impression of Improvement
  • Mood and Physical Symptoms in Depression
  • Quality of Life Enjoyment Satisfaction Questionnaire-Short form

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验